| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |